LEN vs PETS · rev $34.19B vs rev $227.0M
LEN (LEN) versus PetMed Express Inc (PETS) — a side-by-side from cached financials, not a winner call.
LEN (LEN) common stock.
PetMed Express Inc (PETS) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
Latest reported PETS revenue for 2025-03-31 was $227.0M. Net income was -$6.3M. PETS currently screens at market cap $38.5M.
LEN currently screens at market cap $0. PETS currently screens at market cap $38.5M.
Not investment advice. Open the LEN and PETS stock pages for the full models.
Not investment advice.